Ruifang An

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0002-9249-8525

发表论文 25 篇 · 总被引 311 次 · h-index 8

代表论文

• Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi’an: A Cross-Sectional Study (2018 · BioMed Research International · 被引 98)
• Expression of MIF and c-erbB-2 in endometrial cancer (2016 · Molecular Medicine Reports · 被引 48)
• Oteseconazole versus fluconazole for the treatment of severe vulvovaginal candidiasis: a multicenter, randomized, double-blinded, phase 3 trial (2023 · Antimicrobial Agents and Chemotherapy · 被引 24)
• In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China (2022 · Mycopathologia · 被引 22)
• Exploration of pyroptosis-associated prognostic gene signature and lncRNA regulatory network in ovarian cancer (2023 · Computers in Biology and Medicine · 被引 21)
• miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer (2018 · International Journal of Molecular Medicine · 被引 18)